Sort by 'likes'
What is Value for Patients in the Management of Prostate Cancer.
At all stages of and levels of prostate cancer, whether you have low, intermediate, or high risk disease, whether you are newly diagnosed, have recurrent disease or your prostate cancer has advanced and metastasized, the same questions arise. What is…
Effective Mind-Body Strategies to Reduce the Stress of Infertility and Improve Mental Health
Research has shown that our mental state affects the outcomes of treatment in all disease conditions, including infertility, where it may decrease the chances of conception. Couples dealing with infertility go through immense stress, often times severe depression, as the…
History and Future Initiatives for High Risk Smoldering Myeloma Cure
For this second talk in our high risk smoldering myeloma series, we have Prof. Jesus San Miguel from University of Navarra, Spain discuss his team's investigations into high-risk smoldering myeloma and probable cure. For patients with smoldering multiple myeloma, the…
Multiple Myeloma: An Insight into Early Intervention and Personalized Therapies
Myeloma patients are definitely living longer. A decade ago the median survival was 3 to 4 years, while now it is in the range of 8 to 10 years. With all the new drugs and treatments that have been approved,…
MSKCC Expert Dr. Ola Landgren on Can High Risk Disease Progress Cure Myeloma ?
Is high risk disease progress, the key to a cure for all myeloma patients? And what can researchers do to get new therapies to work for more than 30% of relapsed patients? Multiple myeloma has many different treatment options and…